CIK 0001395937
- Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320162505
- Phone
- +1 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-07 | Morrison Briggs Director | Grant or award | +17,000 | 34,836 | ||
| 2023-08-09 | Morrison Briggs Director | Exercise or conversion 10b5-1 | +52,855 | $8.77 | $464K | 70,691 |
| 2023-08-09 | Morrison Briggs Director | Sale 10b5-1 | −52,855 | $18.27 | $965K | 17,836 |
| 2023-08-09 | Morrison Briggs Director | Exercise or conversion · Stock Options (Right to buy) 10b5-1 | −52,855 | 0 | ||
| 2023-07-10 | Morrison Briggs Director | Exercise or conversion 10b5-1 | +52,855 | $8.77 | $464K | 70,691 |
| 2023-07-10 | Morrison Briggs Director | Sale 10b5-1 | −52,855 | $20.40 | $1.1M | 17,836 |
| 2023-07-10 | Morrison Briggs Director | Exercise or conversion · Stock Options (Right to buy) 10b5-1 | −52,855 | 0 | ||
| 2023-06-09 | Morrison Briggs Director | Exercise or conversion 10b5-1 | +24,582 | $6.38 | $157K | 42,418 |
| 2023-06-09 | Morrison Briggs Director | Exercise or conversion 10b5-1 | +28,273 | $8.77 | $248K | 70,691 |
| 2023-06-09 | Morrison Briggs Director | Sale 10b5-1 | −24,582 | $21.18 | $521K | 46,109 |
| 2023-06-09 | Morrison Briggs Director | Sale 10b5-1 | −28,273 | $21.18 | $599K | 17,836 |
| 2023-06-09 | Morrison Briggs Director | Exercise or conversion · Stock Options (Right to buy) 10b5-1 | −28,273 | 0 | ||
| 2023-06-09 | Morrison Briggs Director | Exercise or conversion · Stock Options (Right to buy) 10b5-1 | −24,582 | 0 | ||
| 2023-05-09 | Morrison Briggs Director | Exercise or conversion 10b5-1 | +52,855 | $6.38 | $337K | 70,691 |
| 2023-05-09 | Morrison Briggs Director | Sale 10b5-1 | −52,855 | $21.41 | $1.1M | 17,836 |
| 2023-05-09 | Morrison Briggs Director | Exercise or conversion · Stock Options (Right to buy) 10b5-1 | −52,855 | 0 | ||
| 2023-04-10 | Morrison Briggs Director | Exercise or conversion 10b5-1 | +52,855 | $6.38 | $337K | 70,691 |
| 2023-04-10 | Morrison Briggs Director | Sale 10b5-1 | −52,855 | $19.53 | $1.0M | 17,836 |
| 2023-04-10 | Morrison Briggs Director | Exercise or conversion · Stock Options (Right to buy) 10b5-1 | −52,855 | 0 | ||
| 2023-03-13 | Morrison Briggs President, Head of R&D | Exercise or conversion | +52,854 | $6.38 | $337K | 70,690 |
Page 1 of 5 · 88 trades